Inactive Instrument

Company Zomedica Corp. Toronto S.E.

Equities

ZOM

CA98980M1095

Healthcare Facilities & Services

Business Summary

Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic Devices segment consists of Assisi and PulseVet products. Its TRUFORMA platform comprises point-of-care diagnostic products for disease states in dogs, cats and horses, providing assays for use at the point-of-care that provide reference lab accuracy. Its TRUVIEW platform consists of the TRUVIEW digital cystoscopy instrument providing microscopic images and related pathology services which enable practitioners to receive a pathologist interpretation of the images. The Assisi Loop platform includes a series of products that use targeted pulsed electromagnetic field (tPEMF) therapy.

Number of employees: 144

Sales per Business

USD in Million2022Weight2023Weight Delta
Therapeutics
94.5 %
19 97.9 % 24 94.5 % +28.43%
Diagnostics
5.5 %
0 2.1 % 1 5.5 % +252.17%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
19 100.0 % 25 100.0 % +33.05%

Managers

Managers TitleAgeSince
Chief Executive Officer 67 01/21/01
Director of Finance/CFO 53 16/23/16
Chief Tech/Sci/R&D Officer - 01/18/01
Chief Tech/Sci/R&D Officer - 01/19/01
Chief Operating Officer 63 01/22/01
Director/Board Member 66 16/20/16
General Counsel 56 31/22/31
Human Resources Officer - 02/22/02
Sales & Marketing - -
Corporate Officer/Principal - 17/21/17

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 67 01/21/01
Director/Board Member 62 16/19/16
Director/Board Member 66 16/20/16
Director/Board Member 53 13/21/13
Chairman 68 27/16/27
Director/Board Member 63 27/16/27
Director/Board Member 61 23/22/23
Director/Board Member 54 09/20/09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 979,949,668 964,357,238 ( 98.41 %) 0 98.41 %

Shareholders

NameEquities%Valuation
Vanguard Global Advisers LLC
4.932 %
48,326,991 4.932 % 6 M $
12,240,480 1.249 % 2 M $
Geode Capital Management LLC
1.033 %
10,120,991 1.033 % 1 M $
BlackRock Institutional Trust Co. NA
1.006 %
9,862,981 1.006 % 1 M $
3,110,581 0.3174 % 404 376 $
Brown Brothers Harriman & Co. (Investment Management)
0.2517 %
2,466,532 0.2517 % 320 649 $
2,100,000 0.2143 % 273 000 $
Northern Trust Investments, Inc.(Investment Management)
0.1835 %
1,798,385 0.1835 % 233 790 $
Atom Investors LP
0.1226 %
1,201,048 0.1226 % 156 136 $
1,000,050 0.1021 % 130 007 $

Company contact information

Zomedica Corp.

100 Phoenix Drive Suite 125

48108-2635, Ann Arbor

+

http://www.zomedica.com
address Zomedica Corp.(ZOM)
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW